1 / 9

Designing a Syringe for Injectable Hydrogels

Designing a Syringe for Injectable Hydrogels. John Carradini Department of Biomedical Engineering Griffin Sonaty Department of Biomedical Engineering Faculty Mentor: David Zaharoff, Ph.D. Department of Biomedical Engineering 4 th Annual FEP Honors Research Symposium 8 November 2011.

stamos
Télécharger la présentation

Designing a Syringe for Injectable Hydrogels

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Designing a Syringe for Injectable Hydrogels John Carradini Department of Biomedical Engineering Griffin Sonaty Department of Biomedical Engineering Faculty Mentor: David Zaharoff, Ph.D. Department of Biomedical Engineering 4th Annual FEP Honors Research Symposium 8 November 2011

  2. Carradini, JP and GT Sonaty 4th Annual FEP Honors Research Symposium Cancer • According to the USDHHS, cancer will attack 1 out of every 2 men, and 1 out of every 3 women in America[1] • One of the leading causes of cancerous death is metastasis[2] • We need to find new treatments that eliminate the possibility of metastasis

  3. Carradini, JP and GT Sonaty 4th Annual FEP Honors Research Symposium Interleukin-12 However, there is one problem with IL-12:

  4. Carradini, JP and GT Sonaty 4th Annual FEP Honors Research Symposium IL-12 and Chitosan • IL-12 is toxic to the human body[3] • Chitosan is viscous, and can form a hydrogel at a certain pH • We can mix these to localize the distribution of IL-12 within the confines of the cancerous tumor • Due to viscosity, we must form the hydrogel within the body

  5. Carradini, JP and GT Sonaty 4th Annual FEP Honors Research Symposium Precipitating Chitosan • Chitosan will precipitate at a certain pH, forming a hydrogel • Start with Chitosan dissolved in HCl (acidic) • Add NaOH (basic) to raise the pH • As pH becomes less acidic, Chitosan becomes more likely to precipitate

  6. Carradini, JP and GT Sonaty 4th Annual FEP Honors Research Symposium Delivery Device • Syringe • Must be minimally-invasive • Must be non-reusable • Must keep Chitosan/IL-12 solution in HCl as a liquid while in the device • Must inject Chitosan/IL-12 solution in HCl and NaOH simultaneously at a certain ratio to reach specified pH within the tumor

  7. Carradini, JP and GT Sonaty 4th Annual FEP Honors Research Symposium Research Objectives • Find the pH and concentration levels at which Chitosan precipitates (Sigma, then Low-tox) • Find the ratio to mix NaOH and Chitosan/IL-12 solution in HCl in order to reach proper pH • Design and create a minimally invasive device to directly inject NaOH and Chitosan/IL-12 solution in HCl into a cancerous tumor • Test device and solution on mice (if able)

  8. Carradini, JP and GT Sonaty 4th Annual FEP Honors Research Symposium Schedule • We plan to meet in the Engineering Research Center at least on a bi-weekly basis • We will work collaboratively on the project, providing two perspectives on each aspect of the project • We will work together on the deliverables also, well in advance of deadlines

  9. Carradini, JP and GT Sonaty 4th Annual FEP Honors Research Symposium References • [1] United States Department of Health and Human Services (2011). 12th Report on Carcinogens. Introduction; p. 3. [Cited 3 November 2011] Available from: http://www.knovel.com/web/portal/browse/display?_EXT_KNOVEL_DISPLAY_bookid=4150&VerticalID=0 • [2] Personal Interview with David Zaharoff, Ph.D. on 30 September, 2011 • [3] Cohen, J. (1995). “Clinical Trials: IL-12 Deaths: Explanation and a Puzzle”, Science, Vol. 270, No. 5238, pp. 908. [Cited 3 November 2011] Available from: http://www.sciencemag.org/content/270/5238/908.1.short

More Related